Scholtz & Company, LLC Zoetis Inc. Transaction History
Scholtz & Company, LLC
- $224 Million
- Q3 2025
A detailed history of Scholtz & Company, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Scholtz & Company, LLC holds 21,468 shares of ZTS stock, worth $2.55 Million. This represents 1.4% of its overall portfolio holdings.
Number of Shares
21,468
Previous 23,286
7.81%
Holding current value
$2.55 Million
Previous $3.63 Million
13.49%
% of portfolio
1.4%
Previous 1.62%
Shares
13 transactions
Others Institutions Holding ZTS
# of Institutions
2,057Shares Held
425MCall Options Held
1.82MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA42.3MShares$5.03 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$4.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$2.33 Billion0.1% of portfolio
-
Morgan Stanley New York, NY16.9MShares$2.01 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$1.89 Billion1.96% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $55.6B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...